SCHEMBL96265

SCHEMBL96265

[CH2]CCCCCSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6623653 1.00 TRPA1 (0.41)
SCHEMBL321514 1.00 TRPA1 (0.41)
SCHEMBL16892583 1.00 TRPA1 (0.41)
SCHEMBL5249458 1.00 TRPA1 (0.41)
SCHEMBL321620 1.00
SCHEMBL5073216 1.00 TRPA1 (0.41)
SCHEMBL788709 1.00 TRPA1 (0.41)
SCHEMBL7458419 1.00 TRPA1 (0.41)
SCHEMBL789051 1.00 TRPA1 (0.41)
SCHEMBL9474716 1.00 TRPA1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191482-B1 1,2,3-THIADIAZOL-5YL-UREA DERIVATIVES, USE THEREOF FOR REGULATING PLANT SENESCENCE AND PREPARATIONS CONTAINING THESE DERIVATIVES USTAV EXPERIMENTALNI BOTANIKY AV CR V V I (CZ) 2019-03-27 EP claimed
US-7319100-B2 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2008-01-15 US claimed
US-20070155740-A1 SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-07-05 US claimed
US-7232583-B2 Method for preparing isothiocyanate(s) from cruciferous plant material KINJIRUSHI CO., LTD. (JP) 2007-06-19 US claimed
US-7205306-B2 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2007-04-17 US claimed
EP-1392309-B1 SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS BRISTOL MYERS SQUIBB CO (US) 2007-01-17 EP claimed
EP-1392309-A4 SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS BRISTOL MYERS SQUIBB CO (US) 2006-01-18 EP claimed
EP-1392309-A1 SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-03-03 EP claimed
EP-1379577-A1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES Solutia Inc. (US) 2004-01-14 EP claimed
US-20030171380-A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands BRISTOL-MYERS SQUIBB PHARMA COMPANY, (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) 2003-09-11 US claimed
WO-2002092090-A1 SUBSTITUTED PYRAZINONES, PYRIDINES AND PYRIMIDINES AS CORTICOTROPIN RELEASING FACTOR LIGANDS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-11-21 WO claimed
WO-2002077081-A1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES SOLUTIA, INC. (US) 2002-10-03 WO claimed
WO-2024105148-A1 PLANTS WITH LOW SEED GLUCOSINOLATE CONTENT UNIVERSITY OF COPENHAGEN (DK) 2024-05-23 WO disclosed
US-20240115626-A1 COMPOSITIONS AND METHODS TO INCREASE PRODUCTION OF ISOTHIOCYANATES CHURCH & DWIGHT CO., INC. (US) 2024-04-11 US disclosed
US-20240041733-A1 DENTAL CARE COMPOSITION AND METHOD OF PROMOTING CALCIFICATION IN LIVING BODY TISSUE KINJIRUSHI CO., LTD. (JP) 2024-02-08 US disclosed
US-11801273-B2 Compositions and methods to increase production of isothiocyanates CHURCH & DWIGHT CO., INC. (US) 2023-10-31 US disclosed
US-4354030-A CONTROL OF AQUATIC VEGETATION ELI LILLY AND COMPANY (US) 1982-10-12 US disclosed
EP-0049539-A1 Thiazole derivatives for preparing cephem compounds and processes for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-04-14 EP disclosed
US-4284631-A 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-08-18 US disclosed
EP-0007633-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-02-06 EP disclosed